GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
6Z2M | 6Z2M | H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex | |
6Z2P | B2UR60 | Crystal structure of catalytic inactive OgpA from Akkermansia muciniphila in complex with an O-glycopeptide (glycodrosocin) substrate | |
6Z2P | 6Z2P | Crystal structure of catalytic inactive OgpA from Akkermansia muciniphila in complex with an O-glycopeptide (glycodrosocin) substrate | |
6Z2Q | B2UR60 | Crystal structure of wild type OgpA from Akkermansia muciniphila in complex with an O-glycopeptide (GalGalNAc-TS) product | |
6Z2Q | 6Z2Q | Crystal structure of wild type OgpA from Akkermansia muciniphila in complex with an O-glycopeptide (GalGalNAc-TS) product | |
6Z30 | P11717 | Human cation-independent mannose 6-phosphate/ IGF2 receptor domains 9-10 | |
6Z32 | P11717 | Human cation-independent mannose 6-phosphate/IGF2 receptor domains 7-11 | |
6Z39 | P04062 | Structure of recombinant human beta-glucocerebrosidase in complex with BODIPY functionalised epoxide activity based probe | |
6Z3I | P04062 | Structure of recombinant beta-glucocerebrosidase in complex with bifunctional cyclophellitol aziridine activity based probe | |
6Z3J | P43026 | Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) (crystal form 1) | |
6Z3J | Q6NW40 | Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) (crystal form 1) | |
6Z3M | P43026 | Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) and Neogenin 1 (NEO1). | |
6Z3M | Q6NW40 | Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) and Neogenin 1 (NEO1). | |
6Z3M | P97798 | Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) and Neogenin 1 (NEO1). | |
6Z43 | P0DTC2 | Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex | |
6Z43 | 6Z43 | Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex | |
6Z5G | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, I23 form, citrate pH 4.0, solved by S-SAD | |
6Z5M | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, I23 form, Gly-HCl pH 2.2 | |
6Z5P | A0A0S4TLR1 | The RSL-R8 - sulfonato-calix[8]arene complex, P3 form, TRIS-HCl pH 8.5 | |
6Z5Q | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P3 form, acetate pH 4.0 | |
6Z5R | Q6N9L5 | RC-LH1(16) complex from Rhodopseudomonas palustris | |
6Z5R | Q6N9L4 | RC-LH1(16) complex from Rhodopseudomonas palustris | |
6Z5R | A0A4Z9 | RC-LH1(16) complex from Rhodopseudomonas palustris | |
6Z5R | O83005 | RC-LH1(16) complex from Rhodopseudomonas palustris | |
6Z5R | A0A4Z7 | RC-LH1(16) complex from Rhodopseudomonas palustris | |
6Z5S | Q6N9L4 | RC-LH1(14)-W complex from Rhodopseudomonas palustris | |
6Z5S | Q6N9L5 | RC-LH1(14)-W complex from Rhodopseudomonas palustris | |
6Z5S | A0A4Z9 | RC-LH1(14)-W complex from Rhodopseudomonas palustris | |
6Z5S | O83005 | RC-LH1(14)-W complex from Rhodopseudomonas palustris | |
6Z5S | A0A4Z7 | RC-LH1(14)-W complex from Rhodopseudomonas palustris | |
6Z5S | Q6N1K3 | RC-LH1(14)-W complex from Rhodopseudomonas palustris | |
6Z5W | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, MES pH 6.8 | |
6Z5X | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, acetate pH 4.8 | |
6Z5Z | A0A0S4TLR1 | The RSL-R6 - sulfonato-calix[8]arene complex, P213 form, TRIS-HCl pH 8.5 | |
6Z60 | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, CAPS pH 9.5 | |
6Z62 | A0A0S4TLR1 | The RSL - sulfonato-calix[8]arene complex, P213 form, TRIS-HCl pH 8.5 | |
6Z6V | P02745 | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z6V | P02746 | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z6V | P02747 | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z6V | 6Z6V | Globular head of C1q in complex with the nanobody C1qNb75 | |
6Z79 | A0A291L8F4 | Variant Surface Glycoprotein VSGsur, I3C ("Magic Triangle") derivative used for phasing of the structure and subsequently as a model for molecular replacement of native, mutants, and drug soaks. | |
6Z7A | A0A291L8F4 | Variant Surface Glycoprotein VSGsur | |
6Z7B | A0A291L8F4 | Variant Surface Glycoprotein VSGsur bound to suramin | |
6Z7C | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A | |
6Z7D | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A soaked in 0.77 mM Suramin. | |
6Z7E | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A soaked in 7.7 mM suramin | |
6Z7P | P35828 | Composite model of the Caulobacter crescentus S-layer bound to the O-antigen of lipopolysaccharide | |
6Z8G | Q58NS4 | Crystal structure of VSG13 soaked in 0.5 M used to phase VSG13 to solve the structure. | |
6Z8H | Q58NS4 | Crystal structure of Variant Surface Glycoprotein VSG13 | |
6Z8L | P04746 | Alpha-Amylase in complex with probe fragments |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024